Animalcare Group PLC Notification of Total Voting Rights

RNS Number : 9199R

Animalcare Group PLC

02 January 2025

 

Animalcare Group Plc

(the "Company" or the "Group")

Notification of Total Voting Rights

2 January 2025. For the purposes of the Financial Conduct Authority's Disclosure Guidance and Transparency Rules ("DTRs"), the Company's issued share capital as at 31 December 2024 consisted of 68,976,418 ordinary shares of 20 pence each in the Company ("Ordinary Shares"). No shares are held in Treasury. Therefore, the total number of voting rights in the Company was 68,976,418.

 

The above figure of 68,976,418 may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

For further information, please contact:

Animalcare Group Plc Chris Brewster, Chief Financial Officer and Company Secretary	[phone] [e-mail]
Stifel Nicolaus Europe Limited (Nominated Advisor & Joint Broker) Ben Maddison Nicholas Harland Francis North	Tel: [phone]
Panmure Liberum (Joint Broker) Corporate Finance Freddy Crossley/Emma Earl Corporate Banking Rupert Dearden	[phone]

 

About Animalcare

Animalcare Group plc is a UK AIM-listed international development-focused veterinary sales and marketing organisation. Animalcare operates in seven countries and exports to approximately 40 countries in Europe and worldwide. The Group is focused on bringing new and innovative products to market through its own development pipeline, partnerships and via acquisition.

For more information, please visit www.animalcaregroup.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

TVRBLLFBEFLFBBB